autologous tumor-infiltrating lymphocytes (Women's Hospital School Of Medicine Zhejiang University)

N/A

Report date: 2025/03/14 16:35:58

Base Information

Drug Nameautologous tumor-infiltrating lymphocytes (Women's Hospital School Of Medicine Zhejiang University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerUterine Cervical NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWomen'S Hospital School Of Medicine Zhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesCancer Center Of Sun Yat Sen UniversityShanghai Tongji HospitalQilu Hospital Of Shandong University +[4] 
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerUterine Cervical NeoplasmsOvarian Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A